Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5589 ARTÍCULOS , VIENDO DEL 1756 AL 1770

Exploring the experiences of living with Lewy body dementia: An integrative review

Bentley A, Morgan T, Salifu Y, Walshe C.

J Adv Nurs. 2021 Dec;77(12):4632-4645. doi: 10.1111/jan.14932. Epub 2021 Jun 19.

Progress towards therapies for disease modification in Parkinson's disease

Vijiaratnam N, Simuni T, Bandmann O, Morris HR, Foltynie T.

Lancet Neurol. 2021 Jul;20(7):559-572. doi: 10.1016/S1474-4422(21)00061-2.

Transcranial direct current stimulation provides no clinically important benefits over walking training for improving walking in Parkinson's disease: a systematic review

Nascimento LR, do Carmo WA, de Oliveira GP, Arêas FZDS, Dias FMV.

J Physiother. 2021 Jul;67(3):190-196. doi: 10.1016/j.jphys.2021.06.003. Epub 2021 Jun 17.

Neurotrophic Factors in Parkinson's Disease: Clinical Trials, Open Challenges and Nanoparticle-Mediated Delivery to the Brain

Bondarenko O, Saarma M.

Front Cell Neurosci. 2021 Jun 2;15:682597. doi: 10.3389/fncel.2021.682597. eCollection 2021.

Neurodegenerative Disease Risk in Carriers of Autosomal Recessive Disease

Vieira SRL, Morris HR.

Front Neurol. 2021 Jun 4;12:679927. doi: 10.3389/fneur.2021.679927. eCollection 2021.

CLOVER-DBS: Algorithm-Guided Deep Brain Stimulation-Programming Based on External Sensor Feedback Evaluated in a Prospective, Randomized, Crossover, Double-Blind, Two-Center Study

Wenzel GR, Roediger J, Brücke C, Marcelino ALA, Gülke E, Pötter-Nerger M, Scholtes H, Wynants K, Juárez Paz LM, Kühn AA.

J Parkinsons Dis. 2021;11(4):1887-1899. doi: 10.3233/JPD-202480.

Technology for Measuring and Monitoring Treatment Compliance Remotely

Christie RH, Abbas A, Koesmahargyo V.

J Parkinsons Dis. 2021;11(s1):S77-S81. doi: 10.3233/JPD-212537.

An Emerging Role for Phosphoinositides in the Pathophysiology of Parkinson's Disease

Schechter M, Sharon R.

J Parkinsons Dis. 2021;11(4):1725-1750. doi: 10.3233/JPD-212684.

Comparison of Different Platform Immunoassays for the Measurement of Plasma Alpha-Synuclein in Parkinson's Disease Patients

Youssef P, Kim WS, Halliday GM, Lewis SJG, Dzamko N.

J Parkinsons Dis. 2021;11(4):1761-1772. doi: 10.3233/JPD-212694.

Gene Therapy for Parkinson's Disease Associated with GBA1 Mutations

Abeliovich A, Hefti F, Sevigny J.

J Parkinsons Dis. 2021;11(s2):S183-S188. doi: 10.3233/JPD-212739.

Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2021 Update

McFarthing K, Rafaloff G, Baptista MAS, Wyse RK, Stott SRW.

J Parkinsons Dis. 2021;11(3):891-903. doi: 10.3233/JPD-219006.

Potential for the Repurposing of Adamantane Antivirals for COVID-19

Butterworth RF.

Drugs R D. 2021 Sep;21(3):267-272. doi: 10.1007/s40268-021-00351-6. Epub 2021 Jun 21.

Transdermal nicotine in non-smokers: A systematic review to design COVID-19 clinical trials

Dautzenberg B, Levi A, Adler M, Gaillard R.

Respir Med Res. 2021 Nov;80:100844. doi: 10.1016/j.resmer.2021.100844. Epub 2021 Jun 7.

The promising shadow of microbubble over medical sciences: from fighting wide scope of prevalence disease to cancer eradication

Jangjou A, Meisami AH, Jamali K, Niakan MH, Abbasi M, Shafiee M, Salehi M, Hosseinzadeh A, Amani AM, Vaez A.

J Biomed Sci. 2021 Jun 21;28(1):49. doi: 10.1186/s12929-021-00744-4.

A case of type 1 achalasia associated with Parkinson's disease

Cheval M, Villain C, Gay P, Toméo C, Barrou Z, Verny M.

Rev Neurol (Paris). 2021 Nov;177(9):1198-1199. doi: 10.1016/j.neurol.2020.12.011. Epub 2021 Jun 18.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias